Coloplast B A/S

COLO-B 
(NasdaqOMXC) 
 
dkk 521.00 <%= Resources.Global.txtDown %>
Updated 20/04/2018
Change % -0.34% Stock price decreasing
Change -1.80 Stock price decreasing
Volume 291,109
High DKK 524.00
Low DKK 519.00
Open DKK 522.00
ISIN DK0060448595
Prev close DKK 522.80
# of shares 198.00M
Market cap 103,158M DKK
Intraday

Market closed
Coloplast B A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  521.00 1.6% Stock price increasing 3.9% Stock price increasing -0.4% Stock price decreasing -5.2% Stock price decreasing -8.4% Stock price decreasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
13,909
1,535
899
4,706
10,817
2014
12,428
3,147
2,390
6,283
10,379
2013
11,635
3,672
2,711
6,769
9,364
2012
11,023
3,255
2,194
6,042
10,176
2011
10,172
2,581
1,819
4,478
9,218
2010
9,537
1,995
1,243
3,452
7,771
2009
8,820
1,395
883
2,850
0
2008
8,463
994
715
2,290
0
2007
8,042
749
837
2,804
0
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Smith & Nephew PLC ORD USD0.20 1,352.00 2.3% Stock price increasing 3.2% Stock price increasing 9.4% Stock price increasing -5.3% Stock price decreasing 9.2% Stock price increasing 5.0% Stock price increasing
 
Bristol-Myers Squibb Company 51.17 -12.8% Stock price decreasing -20.0% Stock price decreasing -19.1% Stock price decreasing -20.6% Stock price decreasing -4.3% Stock price decreasing -16.5% Stock price decreasing
 
3M Company 217.75 1.0% Stock price increasing -2.4% Stock price decreasing -11.9% Stock price decreasing -1.6% Stock price decreasing 13.7% Stock price increasing -7.5% Stock price decreasing
Indices Open
 
OMX Copenhagen 20 CAP 1,111.42 0.7% Stock price increasing 0.3% Stock price increasing -4.4% Stock price decreasing -6.1% Stock price decreasing 2.2% Stock price increasing -2.8% Stock price decreasing

Company profile

Coloplast is a leading competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 66% of sales from Europe, 20% from North and South America, and 14% from the rest of the world.

Peers

Indices Last Change  
OMX C20 Cap 1,111.42 -0.1% Stock price decreasing
57,63,54,61,61,27,29,43,52,45
Instruments Last Change  
Smith & Neph.. 1,352.00 0.8% Stock price increasing
Bristol-Myer.. 51.17 -0.9% Stock price decreasing
3M Company 217.75 -0.5% Stock price decreasing

Targets for: Coloplast B A/S

Ritzau Finans
 
Analyst
Target
Date
Coloplast/HSBC: Sænker kursmålet til 557 kr. fra 585 kr.
HSBC
557 op
26/03/18
Coloplast/Danske: Sænker kursmål til 575 kr. fra 620 kr.
Danske Bank
575 op
03/11/17
Coloplast/ABG: Sænker kursmål til 525 kr. efter regnskabsskuffelse
ABG Sundal Collier
525 op
03/11/17
Coloplast/Jefferies: Hæver kursmålet til 421 kr. fra 399 kr.
Jefferies
421 op
31/08/17
Coloplast/Citi: Indleder dækning med
Citigroup
559 ingen ændring
12/06/17
Coloplast/Danske: Kursmål løftes til 650 kr.
Danske Bank
650 op
26/04/17

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 April 2018 15:37:28
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180417.1 - EUROWEB5 - 2018-04-22 16:37:28 - 2018-04-22 15:37:28 - 1000 - Website: OKAY